These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
527 related articles for article (PubMed ID: 15389476)
1. Bacteremia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989-2003). Aisenberg G; Rolston KV; Safdar A Cancer; 2004 Nov; 101(9):2134-40. PubMed ID: 15389476 [TBL] [Abstract][Full Text] [Related]
2. [Bacteremia caused by Alcaligenes (Achromobacter) xylosoxidans. Description of 3 cases and review of the literature]. Ramos JM; Domine M; Ponte MC; Soriano F Enferm Infecc Microbiol Clin; 1996; 14(7):436-40. PubMed ID: 8991439 [TBL] [Abstract][Full Text] [Related]
3. Characteristics of Achromobacter xylosoxidans bacteremia in northern Taiwan. Shie SS; Huang CT; Leu HS J Microbiol Immunol Infect; 2005 Aug; 38(4):277-82. PubMed ID: 16118676 [TBL] [Abstract][Full Text] [Related]
4. [Achromobacter xylosoxidans bacteremia in a patient with community-acquired pneumonia]. de Fernández MI; Bugarín G; Arévalo CE Medicina (B Aires); 2001; 61(1):79-80. PubMed ID: 11265630 [TBL] [Abstract][Full Text] [Related]
5. Alcaligenes xylosoxidans bacteremia: clinical features and microbiological characteristics of isolates. Tsay RW; Lin LC; Chiou CS; Liao JC; Chen CH; Liu CE; Young TG J Microbiol Immunol Infect; 2005 Jun; 38(3):194-9. PubMed ID: 15986070 [TBL] [Abstract][Full Text] [Related]
6. [Bacteremia caused by Stenotrophomonas maltophilia: a clinical-epidemiological study and resistance profile]. Ubeda P; Salavert M; Giner S; Jarque I; López-Aldeguer J; Pérez-Bellés C; Gobernado M Rev Esp Quimioter; 1998 Sep; 11(3):205-15. PubMed ID: 9795306 [TBL] [Abstract][Full Text] [Related]
8. Bacteremia due to Achromobacter xylosoxidans in patients with cancer. Legrand C; Anaissie E Clin Infect Dis; 1992 Feb; 14(2):479-84. PubMed ID: 1554834 [TBL] [Abstract][Full Text] [Related]
9. Recurrent Achromobacter xylosoxidans bacteremia associated with persistent lymph node infection in a patient with hyper-immunoglobulin M syndrome. Weitkamp JH; Tang YW; Haas DW; Midha NK; Crowe JE Clin Infect Dis; 2000 Nov; 31(5):1183-7. PubMed ID: 11073750 [TBL] [Abstract][Full Text] [Related]
10. [Fluoroquinolone prophylaxis utility during chemotherapy-induced severe neutropenia in patients with acute leukemia, with fluoroquinolone resistance high prevalence, in a reference hospital in Mexico City]. Ugarte-Torres A; Villasis-Keever A; Hernández-Bribiesca ME; Crespo-Solis E; Ruiz-Palacios GM; Sifuentes-Osornio J; Ponce-De-León-Garduño A Rev Invest Clin; 2006; 58(6):547-54. PubMed ID: 17432285 [TBL] [Abstract][Full Text] [Related]
11. Urinary tract infection due to Achromobacter xylosoxidans: report of 9 cases. Tena D; González-Praetorius A; Pérez-Balsalobre M; Sancho O; Bisquert J Scand J Infect Dis; 2008; 40(2):84-7. PubMed ID: 17852927 [TBL] [Abstract][Full Text] [Related]
12. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections. Safdar A; Hanna HA; Boktour M; Kontoyiannis DP; Hachem R; Lichtiger B; Freireich EJ; Raad II Cancer; 2004 Dec; 101(12):2859-65. PubMed ID: 15529309 [TBL] [Abstract][Full Text] [Related]
13. Impact of underlying diseases on the clinical characteristics and outcome of primary pyomyositis. Chiu SK; Lin JC; Wang NC; Peng MY; Chang FY J Microbiol Immunol Infect; 2008 Aug; 41(4):286-93. PubMed ID: 18787734 [TBL] [Abstract][Full Text] [Related]
15. Outcome analysis of patients requiring mechanical ventilation with severe community-acquired pneumonia and identified bacterial pathogens. Hu HC; Huang CC; Tsai YH; Lee CH; Hsieh MJ Chang Gung Med J; 2005 Apr; 28(4):229-36. PubMed ID: 16013342 [TBL] [Abstract][Full Text] [Related]
16. Achromobacter xylosoxidans bacteremia: a 10-year analysis of 54 cases. Gómez-Cerezo J; Suárez I; Ríos JJ; Peña P; García de Miguel MJ; de José M; Monteagudo O; Linares P; Barbado-Cano A; Vázquez JJ Eur J Clin Microbiol Infect Dis; 2003 Jun; 22(6):360-3. PubMed ID: 12750959 [TBL] [Abstract][Full Text] [Related]
17. Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome. Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Oh MD; Kim EC; Choe KW Clin Infect Dis; 2004 Sep; 39(6):812-8. PubMed ID: 15472813 [TBL] [Abstract][Full Text] [Related]
18. Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies. Tsai MS; Kuo CY; Wang MC; Wu HC; Chien CC; Liu JW J Microbiol Immunol Infect; 2006 Apr; 39(2):150-4. PubMed ID: 16604248 [TBL] [Abstract][Full Text] [Related]
19. Stenotrophomonas (Xanthomonas) maltophilia as an emerging opportunistic pathogen in association with HIV infection: a 10-year surveillance study. Calza L; Manfredi R; Chiodo F Infection; 2003 Jun; 31(3):155-61. PubMed ID: 12789473 [TBL] [Abstract][Full Text] [Related]
20. Risk factors for candidemia-related mortality at a medical center in central Taiwan. Cheng YR; Lin LC; Young TG; Liu CE; Chen CH; Tsay RW J Microbiol Immunol Infect; 2006 Apr; 39(2):155-61. PubMed ID: 16604249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]